BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Diagnosis
80 results:

  • 1. Germline and Somatic Fumarate Hydratase Testing in Atypical uterine Leiomyomata.
    Kipnis LM; Breen KM; Koeller DR; Levine AS; Yang Z; Jun H; Tayob N; Stokes SM; Hayes CP; Ghazani AA; Hill SJ; Rana HQ
    Cancer Prev Res (Phila); 2024 May; 17(5):201-208. PubMed ID: 38638033
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic profile analysis of leiomyomas with bizarre nuclei and fumarate hydratase deficient leiomyomas: Strengths, weaknesses, and limitations of array-CGH interpretation.
    Fontanges Q; Dubos P; Lesluyes T; Laizet Y; Velasco V; Meléndez B; D'Haene N; Oliva E; Young RH; Mayeur L; Rebier F; Alamé M; Larmonier C; Devouassoux-Shisheboran M; Arnould L; Soubeyran I; Chakiba C; Floquet A; Babin G; Guyon F; Mery E; Le Guellec S; Noël JC; Croce S; Chibon F
    Genes Chromosomes Cancer; 2024 Mar; 63(3):e23229. PubMed ID: 38481055
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The use of Clinicopathological, immunohistochemistry and molecular detection in the diagnosis of fumarate hydratase-deficient uterine leiomyomas.
    Zhang X; Wang C; Shen D
    Pathol Res Pract; 2024 Jan; 253():154916. PubMed ID: 38029712
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Fumarate hydratase deficient uterine leiomyoma: a clinicopathological and molecular analysis of 80 cases].
    Wang XX; Liu Y; Liu LC; Wang YX; Yang J; Hu AJ; Zhang B; Liu CR
    Zhonghua Bing Li Xue Za Zhi; 2023 Jun; 52(6):574-579. PubMed ID: 37263921
    [No Abstract]    [Full Text] [Related]  

  • 5. [FH (Fumarate Hydratase)-deficient renal cell carcinoma: A case report].
    Allaume P; Kammerer-Jacquet SF; Papadopoulos S; Rioux-Leclercq N
    Ann Pathol; 2023 Sep; 43(5):417-420. PubMed ID: 36822902
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas.
    Välimäki N; Jokinen V; Cajuso T; Kuisma H; Taira A; Dagnaud O; Ilves S; Kaukomaa J; Pasanen A; Palin K; Heikinheimo O; Bützow R; Aaltonen LA; Karhu A
    Am J Hum Genet; 2023 Mar; 110(3):460-474. PubMed ID: 36773604
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma.
    Mannan R; Wang X; Bawa PS; Chugh S; Chinnaiyan AK; Rangaswamy R; Zhang Y; Cao X; Smith SC; Trpkov K; Williamson SR; Sangoi AR; Mohanty S; McKenney JK; Gupta S; Magi-Galluzzi C; Argani P; Osunkoya AO; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Hum Pathol; 2023 Apr; 134():102-113. PubMed ID: 36581128
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Primary lymphoma of the uterine cervix: a clinicopathologic study of 13 cases with review of additional 54 cases in the literature.
    Weng X; Huang M; Zhang M; Yang Y; Liu X; Huang Y
    Virchows Arch; 2023 Feb; 482(2):419-429. PubMed ID: 36350409
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer.
    Minoura Y; Takahashi M; Maeda H; Kuwahara S; Tachikawa H; Yamamoto M; Tomioka N; Watanabe K; Sakurai A
    Breast Cancer; 2022 Sep; 29(5):808-813. PubMed ID: 35641852
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Analysis of phenotype and FH gene variation in a pedigree affected with hereditary leiomyomatosis and renal cell carcinoma syndrome].
    Guo Y; Wang L; Xu Z; Bai Y; Wang W; Wu H; Sun Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 May; 39(5):494-498. PubMed ID: 35598264
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Lung metastases and subsequent malignant transformation of a fumarate hydratase -deficient uterine leiomyoma.
    Ahvenainen T; Khamaiseh S; Alkodsi A; Mehine M; Nevala R; Äyräväinen A; Bützow R; Vahteristo P
    Exp Mol Pathol; 2022 Jun; 126():104760. PubMed ID: 35367216
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Functional Characterization of
    Li P; Wu Y; Wu H; Xiong Q; Zhao N; Chen G; Wu C; Xiao H
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163394
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Leiomyoma with nuclear atypia: Rare diseases that present a common diagnostic problem.
    Wei JJ
    Semin Diagn Pathol; 2022 May; 39(3):187-200. PubMed ID: 35144823
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Clinicopathological and Molecular Analysis of Fumarate Hydratase (FH)-deficient Renal Cell Carcinomas with Heterogeneous Loss of FH Expression.
    Anderson WJ; Tsai HK; Sholl LM; Hirsch MS
    Int J Surg Pathol; 2022 Sep; 30(6):606-615. PubMed ID: 35048731
    [No Abstract]    [Full Text] [Related]  

  • 15. uterine leiomyoma with fumarate hydratase deficiency: A case report.
    Huang Y; Zhou Y; Chen X; Fang Q; Cai H; Xie M; Xing Y
    Medicine (Baltimore); 2021 Dec; 100(49):e28142. PubMed ID: 34889279
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cutaneous Leiomyoma: A Clinical Study of 152 Patients.
    Marcoval J; Llobera-Ris C; Moreno-Vílchez C; Penín RM
    Dermatology; 2022; 238(3):587-593. PubMed ID: 34569484
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Hereditary leiomyomatosis and renal cell cancer (hlrcc): Case series and review of the literature.
    Yu Y; Zheng M; Zhu W; Zhao F; Guan B; Shen Q; Yang F; He Q; Li X
    Urol Oncol; 2021 Nov; 39(11):791.e9-791.e16. PubMed ID: 34462205
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [FH-deficient renal cell carcinoma expands the spectrum of renal papillary tumors].
    Rupp N; Moch H
    Pathologe; 2021 Nov; 42(6):560-564. PubMed ID: 34448900
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Clinicopathological features and prognosis of fumarate hydratase deficient renal cell carcinoma].
    Yu YF; He SM; Wu YC; Xiong SW; Shen Q; Li YY; Yang F; He Q; Li XS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):640-646. PubMed ID: 34393221
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Germline Whole-Gene Deletion of FH Diagnosed from Tumor Profiling.
    Ueki A; Sugano K; Misu K; Aimono E; Nakamura K; Tanishima S; Tanaka N; Mikami S; Hirasawa A; Ando M; Yoshida T; Oya M; Nishihara H; Kosaki K
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360727
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.